2004
DOI: 10.1016/s0016-5107(04)01058-2
|View full text |Cite
|
Sign up to set email alerts
|

A First Report of Tumor Seeding by EUS-FNA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2004
2004
2007
2007

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 0 publications
0
3
0
1
Order By: Relevance
“…There is one report of the seeding of cancer cells into the gastric wall after EUS-guided FNA in a patient with pancreatic tail adenocarcinoma. 12 In that case, EUS-guided FNA was performed through the gastric wall, and the surgical procedure did not include resection of the biopsy tract. The author of that report warns that EUS-guided FNA should be avoided or the number of passes should be kept to a minimum if EUS-guided FNA results are unlikely to prevent surgery (e.g., very high pretest likelihood of operable cancer) and the surgical procedure will not include resection of the intestinal biopsy tract (e.g., distal pancreatectomy).…”
Section: Discussionmentioning
confidence: 99%
“…There is one report of the seeding of cancer cells into the gastric wall after EUS-guided FNA in a patient with pancreatic tail adenocarcinoma. 12 In that case, EUS-guided FNA was performed through the gastric wall, and the surgical procedure did not include resection of the biopsy tract. The author of that report warns that EUS-guided FNA should be avoided or the number of passes should be kept to a minimum if EUS-guided FNA results are unlikely to prevent surgery (e.g., very high pretest likelihood of operable cancer) and the surgical procedure will not include resection of the intestinal biopsy tract (e.g., distal pancreatectomy).…”
Section: Discussionmentioning
confidence: 99%
“…[36,37] This may pose a potential problem if the needle tract is not resected with the primary lesion, as in a distal pancreatic tumor. However, further review of this issue is warranted before we can conclude that EUS-FNA should not be performed in potentially resectable pancreatic tumors.…”
Section: Controversies In Eus-fna Of Pancreatic Lesionmentioning
confidence: 99%
“…This is especially true when there is concurrent acute or chronic pancreatititis that may mimic a focal pancreatic cancer. Although the risk of FNA is low, a recent preliminary report of tumor seeding by EUS‐FNA should raise caution when considering FNA of resectable tumors, 22 especially those in the body or tail of the pancreas where the needle track is not resected in the subsequent surgery.…”
Section: Pancreatic Adenocarcinomamentioning
confidence: 99%